March 17, 2020 | Blog News / Updates White Paper

COVID-19 Brings New Realities & Priorities for Your 2020 IR Program

To our friends and partners –

First off, we hope you’re all safe and healthy.  Our team has been working from home since last Friday and have had a fairly seamless transition.  It’s been a hectic 2-3 weeks as our investor call volume has significantly picked up, and we’re all thinking strategically about how we shift our IR program tactics and strategic messaging in the near term.  Many of our clients and friends have had questions for us on guidance policy changes, what we’re seeing with virtual NDRs and conferences, proactive ideas on how to stem the valuation decline, and how we prepare for the impending earnings cycle.

With that in mind, earlier this week we packaged together a set of practical and strategic considerations for our clients to help guide them this volatile time period.  You can find those at this link:

COVID-19 Brings New Realities & Priorities for Your 2020 IR Program

We’re also in the middle of redoing our Alpha IR website, including a significant update to our IR blog.  We’ll be communicating more regularly around big picture IR and transaction/crises topics through that when it launches in the next few weeks.  Until then, please keep the questions coming and please feel free to share this document with your team, management, board, etc.

We wish you all continued good health as we navigate this challenging time together.

About Alpha IR:

The Alpha IR Group is a holistic investor relations and transactions/crisis consulting firm that protects, enhances and builds the investment brands of America’s leading companies. We bring over 100 years of collective Wall Street, financial, and large agency experience, while retaining a small company, holistic approach. With deep sector expertise and senior-driven programs, Alpha IR is the right choice to manage our clients’ reputations, credibility, and ultimately, their valuation.  For more information please see

Alpha-IR Group
P: (312) 445-2870